Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 675 participants.

Also called NCT02506140

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 675 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02506140
Other papers using this trial's data
  • Impact of smoking on platelet function of ticagrelor versus clopidogrel in minor stroke or transient ischaemic attack European journal of neurology, 2020-05 DOI, PubMed 32052517

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02506140. Randomized; single masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2017-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
Acronym
PRINCE
Condition
Stroke
Condition
Ischemic Attack, Transient
Intervention (Drug)
Ticagrelor and Acetylsalicylic acid
Intervention (Drug)
Clopidogrel and Acetylsalicylic acid
Lead sponsor
Beijing Tiantan Hospital (class: other)
Collaborator
Beijing Municipal Science & Technology Commission (class: other)

Record details

Record id
cardio:ct-nct02506140
Content hash
b138978862e339bb0396b37c94ff34347e78d5eecafdcc1ccf81cbcd1bd6bafb